2024 HCPCS Code Q0220
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg
TAGS: vaccine tixagevimab certain history vaccination weighing severely moderate prophylaxis compromised recommended individuals systems adverse known pediatric older years reaction severe immune either least available
Short Description | Tixagev and cilgav, 300mg |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | December 08, 2021 |
HCPCS Code Added Date | December 08, 2021 |
HCPCS Pricing Indicator Code | 54 - Vaccinations |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | V - Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95 |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q4122 - Dermacell, awm, porous sq cm
- Q4123 - Alloskin
- Q4124 - Oasis tri-layer wound matrix
- Q4125 - Arthroflex
- Q4126 - Memoderm/derma/tranz/integup
- Q4127 - Talymed
- Q4128 - Flexhd/allopatchhd/sq cm
- Q4129 - Unite biomatrix
- Q4130 - Strattice tm
- Q4131 - Epifix or epicord
- Q4132 - Grafix core, grafixpl core
- Q4133 - Grafix stravix prime pl sqcm
- Q4134 - Hmatrix
- Q4135 - Mediskin
- Q4136 - Ezderm
- Q4137 - Amnioexcel biodexcel 1sq cm
- Q4138 - Biodfence dryflex, 1cm
- Q4139 - Amnio or biodmatrix, inj 1cc
- Q4140 - Biodfence 1cm
- Q4141 - Alloskin ac, 1 cm